DSM-Firmenich revolutionizes protein production with carbon-neutral single-cell proteins

NETHERLANDS- Global human and animal nutrition specialist DSM-Firmenich has unveiled a groundbreaking advancement: new single-cell proteins (SCP) with the capability to generate net-zero carbon proteins.  This development is set to play a crucial role in enhancing the sustainability of food systems by reducing the dependency on traditional inputs associated with animal production, such as fertilizers, deforestation, and excessive water usage.…

Read More

dsm-firmenich halfway to 100,000 tons of CO2e reduction with Boaver  

NETHERLANDS- Leading human and animal nutrition specialist, dsm-firmenich, reports that, since it was first developed, Bovaer has enabled the reduction of 50,000 tons of CO2e equivalent. Dsm-firmenich is looking to achieve 100,000 tons of CO2e as the next milestone for the feed additive, which is targeted at methane emissions reduction in ruminants. During its unveiling, DSM explained that the development…

Read More

Dutch flavor and fragrance company dsm-firmenich completes US$300M acquisition of Adare Biome

FRANCE- Dsm-firmenich, a leading global innovator in nutrition, health, and beauty, has completed the acquisition of French-based postbiotics pioneer Adare Biome for an enterprise value of €275 (US$299.64) million.  “The Adare Biome teams will enable us to accelerate the creation of next-generation biotics to support the health of people and animals,” said Philip Eykerman, President of Health, Nutrition & Care.…

Read More

Nutrition giant DSM-Firmenich ramps up restructuring plans for its vitamins business in light of marketing challenges 

NETHERLANDS- DSM-Firmenich has announced that it would accelerate its plans to restructure its vitamin business to improve its performance as the vitamin markets continue weakening, negatively affecting its outlook for the second half of 2023. “The challenging conditions in vitamin activities have further deteriorated during June, affecting both pricing and volumes, where the company had expected stable to improving conditions…

Read More

DSM-Firmenich files petition against 2nd Chinese firm on allegations of unlawfully using its patented technology

CHINA- DSM-Firmenich has initiated legal action for patent infringement against Shandong Haineng Bioengineering only weeks after taking similar measures against China-based Anhui Shengda Bio-pharm Co and Zhejiang Shengda Bio-pharm – a biotin manufacturer and supplier collectively referred to as Shengda.  The recently merged nutrition specialist took action against Shandong Haineng Bioengineering Co. Ltd., alleging that certain Haineng swine compound premix…

Read More